Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0R2KJ
|
||||
| Former ID |
DAP000435
|
||||
| Drug Name |
Dicloxacillin
|
||||
| Synonyms |
Dichloroxacillin; Diclossacillina; Dicloxaciclin; Dicloxacilin; Dicloxacilina; Dicloxacilline; Dicloxacillinum; Dicloxacycline; Dycill; Dynapen; Maclicine; Methyldichlorophenylisoxazolylpenicillin; Pathocil; Diclossacillina [DCIT]; Dicloxacillin sodium; BRL 1702; Diclocil (TN); Dicloxacilina [INN-Spanish]; Dicloxacilline [INN-French]; Dicloxacillinum [INN-Latin]; R-13423; Dicloxacillin (USAN/INN); Dicloxacillin [USAN:INN:BAN]; Dicloxacillin, Monosodium Salt, Mono-Hydrate; (2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolylpenicillin; 6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; 6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid; 6beta-{[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carboxamido}-2,2-dimethylpenam-3alpha-carboxylic acid
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Bacterial infections [ICD9: 001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104; ICD10:A00-B99] | Approved | [538204] | ||
| Therapeutic Class |
Antibiotics
|
||||
| Company |
Sandoz Inc
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H17Cl2N3O5S
|
||||
| Canonical SMILES |
CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)<br />(C)C)C(=O)O
|
||||
| InChI |
1S/C19H17Cl2N3O5S/c1-7-10(12(23-29-7)11-8(20)5-4-6-9(11)21)15(25)22-13-16(26)24-14(18(27)28)19(2,3)30-17(13)24/h4-6,13-14,17H,1-3H3,(H,22,25)(H,27,28)/t13-,14+,17-/m1/s1
|
||||
| InChIKey |
YFAGHNZHGGCZAX-JKIFEVAISA-N
|
||||
| CAS Number |
CAS 3116-76-5
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
9165, 7849407, 7979067, 8163742, 11335833, 11361072, 11363826, 11366388, 11368950, 11371491, 11374192, 11377112, 11462044, 11466478, 11467598, 11484777, 11486175, 11488797, 11490202, 11492322, 11494746, 14960168, 29286044, 46508182, 47216776, 47440256, 47736481, 47810752, 47810753, 48259229, 48334496, 48415884, 50064670, 50783422, 57304808, 57330050, 85788067, 103234555, 104133803, 104344973, 117541882, 124766323, 134222806, 134337731, 134981835, 135912430, 136357162, 137003736, 140093221, 142567322
|
||||
| ChEBI ID |
ChEBI:4511
|
||||
| SuperDrug ATC ID |
J01CF01
|
||||
| SuperDrug CAS ID |
cas=003116765
|
||||
| Target and Pathway | |||||
| Target(s) | DNA | Target Info | Binder | [537799] | |
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.